Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > the podcast says it was released today.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12061)
•••
Comment by ScienceFirston Nov 15, 2022 9:06am
67 Views
Post# 35099315

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:the podcast says it was released today.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:the podcast says it was released today.

GrahamB, the boring accountant that only focuses on the past, is trying to tell us that VPT's move to a bigger location just for fun, just to burn money!!!

He posts like if there had been no evolution since VMS 1.0, when VMS 3.0 is ready and VMS 4.0 is in the work!

He downplays GEHC' seriousness!
 

He downplays any upside and tries to warn us that @0.27$, the downside is risky!  That the risk/reward ration is not worth it!!

100% of his posts are 100% negative and he posts only on VPT!  The perfect profile of a short.

Just ignore this clown.




 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities